Cytek Biosciences (CTKB) Retained Earnings (2020 - 2026)

Cytek Biosciences has reported Retained Earnings for 7 years, with the latest figure at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 489.0% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 489.0% YoY), and the FY2025 full-year result was $2.2 million, up 106.37% from the prior year.
• Retained Earnings for Q1 2026 stood at $2.4 million, up from $2.2 million in the prior quarter.
• The five-year high for Retained Earnings was $2.4 million in Q1 2026, with the low at -$35.2 million in Q4 2024.
• Historically, Retained Earnings has averaged -$12.3 million across 5 years, with a median of -$1.6 million in 2024.
• Annual changes were most pronounced in 2023 — Retained Earnings slumped 6443.58% — and 2025, when it jumped 712.87%.
• Cytek Biosciences' Retained Earnings stood at -$17.0 million in 2022, then plunged by 71.33% to -$29.2 million in 2023, then decreased by 20.64% to -$35.2 million in 2024, then soared by 106.37% to $2.2 million in 2025, then climbed by 5.71% to $2.4 million in 2026.
• The last three Retained Earnings figures came in at $2.4 million (Q1 2026), $2.2 million (Q4 2025), and $821000.0 (Q3 2025), per Business Quant data.